| INTRODUC TI ON
Alzheimer's disease (AD) is a brain dysfunction, whereby the patient's mental abilities gradually disappear. In fact, it is one of the most common neurodegenerative diseases, accounting for more than 80% of dementia in the elderly. Symptoms of the disease begin with the loss of working memory and continue with a progressive decline in mental performance and learning ability. This disease is associated with the amyloid plaques formation, neurofibrillary tangles (NFTs), hyperphosphorylation of tau protein, loss of neuronal synapses, inflammation, oxidative damage and finally necrosis and apoptosis of brain cells.
1 Amyloid plaques or senile plaques are extracellular deposits of amyloid beta (Aβ) in the brain tissue.
Neurotoxicity due to the increase of Aβ oligomers has been extensively reported. 2, 3 Injection of micromolar concentration of Aβ peptide into the brain induces beta-amyloidosis and its related pathology with cognitive impairment. 4 An important fact is that a high density of beta amyloid deposits in the brain of Alzheimer's patients are mainly seen in the hippocampus and cortex, which are two important areas associated with learning and memory. 
Summary
Alzheimer's disease (AD) is a neurodegenerative disorder with an incompletely defined aetiology that is associated with memory and cognitive impairment. Currently available therapeutics only provide temporary assistance with symptoms. In spite of plentiful research in the field and the generation of thousands of studies, much is still to be clarified on precise mechanisms of pathobiology, prevention modalities, disease course and cure. Netrin-1, a laminin family protein, is said to have anti-inflammatory and anti-apoptotic effects and has a key role in neurogenesis and morphogenesis of neural structures. Accordingly, this study was designed to investigate protective effects of bilateral intrahippocampal fissure microinjections of netrin-1 on memory impairment in rat model of AD. Concomitant administration of netrin-1 with amyloid beta 1-42 (Aβ 1-42 ) improved cognitive dysfunction in novel object recognition task (NOR), ameliorated impaired spatial memory in Morris water maze (MWM) setting, increased neuronal density and reduced amyloid aggregation in rat AD model.
Netrin-1 was also seen to prevent Aβ 1-42 -induced caspase-3, caspase-7 and NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) activation. Therefore, based on the data reported here, netrin-1 may be a promising biologic therapeutic that addresses the memory and neuronal loss associated with AD.
K E Y W O R D S
Alzheimer's disease, amyloid beta 1-42, learning and memory, netrin-1 DSCAM1, and two isoforms of integrin (α6β4 and α3β4). 5 Netrin-1 has a key role in Axonal guidance, neuronal migration and morphogenesis of neural structures in the central nervous system. 6 A recent study has shown that connecting the netrin-1 to UNC5B via the PI3K signalling pathway prevents the pro-apoptotic activity of UNC5B and increases neuronal survival. 7 Other studies
show that the activation of caspases, which are a major mediator of apoptosis, occurs in the absence of netrin-1, 8 and in some cancers, cell death is inhibited by decreasing the expression of the UNC5B receptor. 9 In humans, netrin-1 has a regulatory role on stem cell migration and inflammation. The regulation of netrin-1 expression in various tissues and diseases is not well understood, but NF-κB is thought to be responsible for increasing the expression of netrin-1 in inflammatory bowel diseases, 10 and recent studies on NF-κB indicate the drugs that targeted this factor may have beneficial effects on memory disorders. 11 Reducing netrin-1 release will increase inflammation in tissue damage, moreover netrin-1 inhibits the migration of leukocytes to inflamed areas.
This suggests that up-regulation of netrin-1 has protective effect on inflammatory processes. Also, immigration and development of stem cells in the nervous system is a process dependent on netrin-1. 12, 13 Netrin-1 is a neuronal growth factor and netrin-1 binding suppresses Aβ peptide production in brain slices from
Alzheimer model transgenic mice. In this mouse model, decreased netrin-1 expression is associated with increased Aβ concentration, thus supporting netrin-1 as a key regulator of Aβ production. 
| RE SULTS
Due to the similarity of the results for the control and N groups to the sham group for all studies, the data for those groups are not shown.
| Netrin-1 alleviated Aβ-induced memory deficits in novel object recognition task
As shown in Figure 1A , hippocampal-dependent working object memory was significantly impaired in Aβ-inoculated animals as indicated by the lack of a significant difference in the exploration times for the familiar and novel objects (P > 0.05).
In animals that had received netrin-1 as well as Aβ inoculation, however, novel object exploring time significantly increased in comparison to identical object. In sham group, novel object and identical exploring times were statistically different.
Preference index in Aβ-inoculated animals was also affected in comparison with sham group and animals that had received netrin-1 as well as Aβ inoculation (P < 0.01). Also, netrin-1 concomitant administration could efficiently improve preference index and recognition memory nearly to sham group ( Figure 1B ).
| Netrin-1 improved Aβ-induced spatial learning and memory impairment
To investigate netrin-1 effects on Aβ-induced spatial learning and memory impairment, the Morris water maze test was used.
As noted, escape latency was gradually reduced from the first day till the last day of the test in Aβ-received animals which signifies the learning process during the test. Yet, this parameter was significantly longer in Aβ-inoculated animals than other groups during 
| Netrin-1 attenuated NF-κB concentration in CA1 region
Aβ-inoculated rats exhibited significantly elevated of NF-κB levels in hippocampal tissue supernatant compared to the sham group.
Treatment with netrin-1 significantly attenuated increased NF-κB content in Aβ-inoculated rats in comparison to the Aβ group (P < 0.0001) ( Figure 5 ).
| Netrin-1 inhibited caspase-3 and caspase-7 activity
Enzymatic assay showed the inhibitory effects of netrin-1 on caspase-3/7 activity. Caspase-3 and caspase-7 are predominant pro-apoptotic caspases that are activated in amyloid-beta precursor protein (APP)
cleavage and Aβ production. These caspases are responsible for subsequent neuronal death in Alzheimer's disease. Aβ 1-42 intrahippocampal injection led to an increase in caspase-3/7 activity. This increase was prevented by netrin-1 as shown in Figure 6 (P < 0.05).
| D ISCUSS I ON
In this study, we investigated the protective effects of the netrin-1 peptide on memory impairment in a rat model of AD. Direct injection of Aβ 1-42 into the hippocampus resulted in learning and memory impairment that is very similar to clinical manifestations of the disease in humans. 16 Exogenous administration of netrin-1 in hif could improve Aβ-induced neuronal loss, Aβ plaque In this study, escape latencies in MWM spatial memory test were increased among Aβ-inoculated rats until the third training day.
Concomitant treatment with netrin in Aβ-inoculated animals decreased escape latencies and brought them to the levels of the sham operated animals from the first training day. This finding shows the memory enhancing effect of the agent on the memory consolidation process. Probe test data also confirmed positive effects on memory retrival. These findings are in agreement with many studies in the spatial memory of the AD animal model.
17,18
Increased exploration time of the new object and the preference index in NOR test are other findings of our study that emphasizes the potential capability of the agent on memory in AD.
A myriad of possible mechanisms are imagined to explain our findings, but we investigated more relevant ones in this study.
Increased neuronal density, reduced amyloid plaques in affected areas, decreased NF-κB level and supressed caspase-3/7 activity have been surveyed here and seem to explain the effects well. 
| CON CLUS ION
Our findings showed that netrin-1 can improve spatial memory and novel object recognition task possibly through neuronal survival and F I G U R E 7 Model for the hypothetical mechanism of netrin-1 on cognition deficits in a rat model of AD anti-inflammatory approaches. Therefore, we may think of netrin-1 as a potential protective substance for neuronal damage and memory loss in research setting. Further, ongoing work is needed to unveil other untouched characteristics of the agent in neurodegenerative disorders.
| MATERIAL S AND ME THODS

| Animals
In this study, we used 50 male Wistar rats (250-300 g). Animals were randomly divided into five equal groups of 10 animals each; the groups consisted of untreated/uninoculated rats (control) 
| Preparation of Aβ 1-42 solution
To 
| Surgery
Alzheimer's disease-like pathology was induced with bilateral CA1 microinjections of Aβ 1-42 (22 μg/4 μL PBS) under general anaesthesia with intra-peritoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). Anaesthetized animals were then placed in a stereotaxic instrument (Stoelting, 620 Wheat Lane Wood Dale, IL 60191, USA) with the incisor bar set at 3.3 mm below the interaural line. The head skin was clean shaved and scrubbed with povidone iodine. The skull was exposed through an incision on the midline. Two symmetrical bur holes were made at the skull surface.
Aβ was injected at a rate of 0.5 μL/min with a Hamilton syringe in the CA1 region based on the following coordinates: AP, −3.5 mm from bregma; laterality, ±2 mm from midline; and DV, −2.8 mm from the skull surface. In order to maximize Aβ distribution, the syringe was left in situ for 2 minutes before retraction, and slowly removed. In Aβ+N and N groups, netrin-1 (800 ng/5 μL PBS) was bilaterally injected into the hippocampal fissure (hif) at a rate of 0.5 μL/min using the same Hamilton syringe into the coordinates targeting the hif region (AP, −4.7 mm; laterality, ±3.4 mm; and DV, −3.4 mm) 30 minutes later. 30 In the sham group, however, sterile PBS injected in the respective areas instead according to the coordinates, volumes and methods mentioned earlier. After completion of the surgical procedure, the scalp was sutured and tetracycline ointment was sprinkled on the wound to prevent infection.
Animals were placed on a warming pad in individual cages until full recovery from anaesthesia. They were then kept in group cages for a 14-day recovery.
| Novel object recognition test
The NOR test was used to evaluate the effects of Aβ 1-42 inoculation and concomitant treatment with netrin-1 on hippocampusdependent working object memory. 31 The NOR test is based on the natural tendency of rats to spend more time exploring a novel object than a familiar one. For habituation, the animals were allowed to explore the empty arena (30 cm × 70 cm × 70 cm)
for 5 minutes the day before starting the test. On Day 15 postsurgery, animals were individually placed in the arena containing two identical objects fixed to the floor at an equal distance to the walls and each other. After 5 minutes, the animal was removed and returned to its cage. One hour later, the rat was again placed into the arena in which a familiar object together with a novel object were put to test recognition memory. The new object was the same height and volume but was different in shape and colour as the familiar object. Exploration of the object was defined as the animal's nose being in the zone at a distance of less than 2 cm.
Animals who did not explore the objects in this phase were excluded from the test. To prevent any scent marking, objects were cleaned and dried with an alcoholic pad after each step. Exploring time for each object was recorded with respective chronometers.
Preference index (PI) was then calculated based on the following formula:
where T N is the novel object spent time and T F as familiar object spent time. 
| Morris water maze test
The MWM test was performed to study spatial memory on Day 16 post-surgery. Briefly, a circular pool (150 cm diameter and 75 cm height) with a black inner surface was filled with plain water (21 ± 2°C) to a depth of 50 cm and divided into four quadrants. A transparent platform (16 cm diameter) was submerged 1 cm below the water surface and placed at the midpoint of southwest quadrant.
Memory-acquisition trials were performed four times a day for 4 consecutive days and escape latencies (time to find hidden platform)
were recorded using an on-board tracking shot system (Radiab software 2.1, Nomirei Co., Tehran Iran). For each trial, an individual rat was placed in the water at a random quadrant and allowed to freely swim until they could reach the platform and left there for an additional 30 seconds to rest. Rats that failed to find the platform within 60 seconds were manually placed on the platform for a 30 seconds rest and then were returned to their cages. Memory retention (probe) test was made in a platform-free MWM pool on Day 5 in which each rat allowed to freely swim for 60 seconds inside the pool to measure the time spent in target quadrant that was previously equipped with platform and the swimming speed. 
| Euthanasia and tissue preparation
After behavioural studies on Day 21 post-surgery, histological studies were made on hippocampal samples of five rats in each group that were randomly chosen. The rats were deeply anaesthetized with a mixture of ketamine and xylazine. Transcardial perfusion of normal saline and 10% formaldehyde solution was made to fix the brain tissues.
The brains were then removed and kept in plastic containers filled with 10% formaldehyde solution at ambient temperature for 24 hours.
The remaining five rats in each group were used for biochemical analysis and decapitated under deep anaesthesia according to the guidelines for animal experimentation at Tehran University of Medical Sciences. Brains were dissected and rapidly frozen on liquid nitrogen and then stored at −80°C until assay.
| Tissue staining
| Hematoxylin and eosin (H & E)
Twenty-four hours post fixation, hippocampal samples were microdissected, dehydrated and embedded in paraffin. Five micrometer tissue sections were made using a rotary microtome and air-dried on glass slides. They were dewaxed and stained with H & E for 10 minutes and 3 seconds respectively. Dehydration was finally performed with graded alcohol.
| Cresyl violet
To detect Nissl bodies in the neuronal cytoplasm, cresyl violet staining technique was used. In order to prepare the solution, 0.4 g cresyl violet acetate powder (Sigma -Aldrich) was added to 400 mL of distilled water and mixed for at least 10 minutes to ensure maximum solubility. The solution was then filtered with filter paper and used for staining. Staining protocol was the same as H & E staining technique and lasted 3 minutes.
| Congo red
Additional sections of 8 μm were prepared and pretreated with 0.1% hematoxylin solution in pH 2.5 and stained in 0.2% Congo red reagent.
Sections were then dehydrated with mounted graded alcohol and visualized under light microscope for red stained amyloid deposit detection.
Photographs were made with a magnification of 20 using the Micrometrics SE Premium software. Neurons with a distinct cytoplasmic membrane and a clear nucleus were counted with free downloadable Image J software (version 1.51, http://imageJ.nih.govij).
| Determination of NF-κB level
Hippocampal tissues were homogenized in homogenization buffer mixed with protease and enzyme inhibitors and then centrifuged at 3500 × g at 4°C for 5 minutes. Supernatants were taken and stored at −80°C until assay. To investigate netrin-1 effects on NF-κB activation, NF-κB concentration was measured by ELISA non-radioactive method with NF-κB p65 Transcription Factor Assay kit (Abcam, Cambridge, United Kingdom) according to the manufacturer's protocol. 
| Caspase-3/7 activity assay
| Statistical methods
Data expressed as mean ± SEM and compared with one-way ANOVA and repeated measure ANOVA using a free 30 days' trial Graph pad prism 6.0. Sidak and Tukey post hoc tests also used to show the differences. P < 0.05 was considered significant.
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